Group Milleri Streptococci in perianal infections

被引:4
作者
Stelzmueller, I. [3 ]
Aigner, F. [3 ]
Albright, J. [4 ]
Margreiter, R. [3 ]
Fille, M. [5 ]
Swenson, B. R. [1 ]
Dossett, L. [2 ]
Bonatti, H. [1 ]
机构
[1] Univ Virginia Hlth Syst, Dept Surg, Charlottesville, VA USA
[2] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA
[3] Innsbruck Med Univ, Dept Gen & Transplant Surg, Innsbruck, Austria
[4] S Bay Med Ctr, Dept Surg, Harbor City, CA USA
[5] Innsbruck Med Univ, Dept Hyg Microbiol & Social Med, Innsbruck, Austria
关键词
Perianal infection; Streptococcus milleri; recurrence; antibiotics;
D O I
10.1111/j.1463-1318.2009.01847.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Anal abscesses are commonly associated with fistulas-in-ano and are usually polymicrobial in nature, with gram-negative rods and anaerobes being the most prevalent isolates. Group Milleri Streptococci (GMS) comprise a heterogeneous group of cocci, which are capable of causing severe purulent infection with a high recurrence rate. Method All anorectal infections caused by GMS, which were identified at our centre during a 4-year period were retrospectively analysed. The 18 patients with GMS-positive anorectal abscesses were matched with 36 GMS-negative anorectal abscesses to identify outcome characteristics of this clinical entity. Results During the study period, 358 patients underwent surgical treatment for anal infections; GMS were isolated in 46 individuals (13%) including 18 perianal abscesses, 11 pilonidal sinuses, eight fistulae in and nine miscellaneous infections. Seventy-two per cent of perianal GMS infections were polymicrobial with E. coli and Bacteroides fragilis being the predominant second bacteria. Nine patients (20%) developed recurrent abscesses and fistulae-in-ano and underwent additional surgical interventions with resolution at follow-up. Additional antibiotic treatment was administered in 10 patients with complex anal infections. Matched pair analysis revealed that GMS-positive perianal abscesses were more commonly polymicrobial, and that the recurrence rate was higher (55.6% GMS-positive and 22.2% GMS-negative patients, P = 0.017). Conclusions Our data confirm the propensity of GMS to form deep and recurrent abscesses with a higher recurrence rate than non-GMS infections. First-line treatment includes surgical drainage, and antibiotic treatment may be useful in selected patients.
引用
收藏
页码:E121 / E127
页数:7
相关论文
共 50 条
  • [31] Comparison of antibiotic susceptibility in viridans group streptococci in low and high antibiotic-prescribing General Practices
    Goldsmith, C. E.
    Hara, Y.
    Sato, T.
    Nakajima, T.
    Nakanishi, S.
    Mason, C.
    Moore, J. E.
    Matsuda, M.
    Coulter, W. A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (02) : 204 - 207
  • [32] Multiple Deep-seated Dentofacial Abscesses Caused by Multidrug-resistant Viridans Group Streptococci
    Fukushima, Shinnosuke
    Hagiya, Hideharu
    Mizuta, Yuki
    Nakano, Yasuhiro
    Takahara, Masahiro
    Okamoto, Kayo
    Hayashi, Yuko
    Yamada, Kiyoshi
    Hasegawa, Kou
    Otsuka, Fumio
    INTERNAL MEDICINE, 2020, 59 (16) : 2067 - 2070
  • [33] Early hospital discharge of infants born to group B streptococci-positive mothers: a decision analysis
    Berger, M. B.
    Xu, X.
    Williams, J. A.
    Van de Ven, C. J. M.
    Mozurkewich, E. L.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (04) : 439 - 448
  • [34] DURATION OF POSITIVE THROAT-CULTURES FOR GROUP-A STREPTOCOCCI AFTER INITIATION OF ANTIBIOTIC-THERAPY
    SNELLMAN, LW
    STANG, HJ
    STANG, JM
    JOHNSON, DR
    KAPLAN, EL
    PEDIATRICS, 1993, 91 (06) : 1166 - 1170
  • [35] Neonatal Immune Responses during Group B Streptococcal Infections
    Upadhyay, Kirtikumar
    Talati, Ajay J.
    JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2017, 12 (03) : 164 - 170
  • [36] Perianal Infections in the Phase before Engraftment after Allogeneic Hematopoietic Stem Cell Transplantations: A Study of the Incidence, Risk Factors, and Clinical Outcomes
    Mo, Xiao-Dong
    Yan, Xia
    Hu, Wei
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Xu, Xiao-Dong
    Wang, Lin-Nan
    He, Xin-Xin
    Yan, Chen-Hua
    Chen, Huan
    Chen, Yu-Hong
    Liu, Kai-Yan
    Huang, Xiao-Jun
    ACTA HAEMATOLOGICA, 2018, 139 (01) : 19 - 27
  • [37] New Species Genetic Approach To Identify Strains of Mitis Group Streptococci That Are Donors of Rifampin Resistance to Streptococcus pneumoniae
    Ferrandiz, Maria-Jose
    Ardanuy, Carmen
    Linares, Josefina
    Balsalobre, Luz
    Teresa Garcia, Maria
    de la Campa, Adela G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (01) : 368 - 372
  • [38] Recent patterns in antibiotic use for children with group A streptococcal infections in Japan
    Okubo, Yusuke
    Michihata, Nobuaki
    Morisaki, Naho
    Kinoshita, Noriko
    Miyairi, Isao
    Urayama, Kevin Y.
    Yasunaga, Hideo
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 13 : 55 - 59
  • [39] Prevention of perinatal group B streptococcal infections: A review with an Indian perspective
    Narava, S.
    Rajaram, G.
    Ramadevi, A.
    Prakash, G. V.
    Mackenzie, S.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 32 (01) : 6 - 12
  • [40] Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens
    Pericas, Juan M.
    Nathavitharana, Ruvandhi
    Garcia-de-la-Maria, Cristina
    Falces, Caries
    Ambrosioni, Juan
    Almela, Manel
    Garcia-Gonzalez, Javier
    Quintana, Eduard
    Marco, Francesc
    Moreno, Asuncion
    Bayer, Arnold S.
    Miro, Jose M.
    Karchmer, Adolf W.
    Tellez, Adrian
    Hernandez-Meneses, Marta
    Casals, Climent
    Vila, Jordi
    Sandoval, Elena
    Pare, Juan C.
    Falces, Carlos
    Pereda, Daniel
    Cartana, Ramon
    Ninot, Salvador
    Azqueta, Manel
    Sitges, Marta
    Vidal, Barbara
    Pomar, Jose L.
    Castella, Manuel
    Tolosana, Jose M.
    Ortiz, Jose
    Fita, Guillermina
    Rovira, Irene
    Fuster, David
    Ramirez, Jose
    Brunet, Merce
    Soy, Dolors
    Castro, Pedro
    Llopis, Jaume
    Garcia-Pares, Delia
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)